Literature DB >> 7570421

Three cases of pulmonary aspergilloma in adult patients with cystic fibrosis.

C P Maguire1, J P Hayes, M Hayes, J Masterson, M X FitzGerald.   

Abstract

Pulmonary aspergillomas usually occur when Aspergillus fungi colonise lung tissue previously damaged by disease. Pulmonary aspergillomas in three adult patients with cystic fibrosis are reported--an association not previously described. At the time of diagnosis all three patients had previous long term colonisation with Aspergillus fumigatus and severe advanced destructive lung disease with lung function less than 25% of the predicted normal values. It is likely that, with increasing survival in cystic fibrosis, more adult patients will develop aspergillomas during the protracted phase of end stage lung disease that characterises the terminal years of this condition.

Entities:  

Mesh:

Year:  1995        PMID: 7570421      PMCID: PMC474659          DOI: 10.1136/thx.50.7.805

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

1.  Treatment of pulmonary aspergilloma with itraconazole.

Authors:  J H Campbell; J H Winter; M D Richardson; G S Shankland; S W Banham
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

2.  Cystic fibrosis and allergic bronchopulmonary aspergillosis.

Authors:  E J Simmonds; J M Littlewood; E G Evans
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

3.  Pulmonary aspergilloma. Diagnostic and therapeutic considerations.

Authors:  R A Glimp; A S Bayer
Journal:  Arch Intern Med       Date:  1983-02

4.  Unusual clustering of allergic bronchopulmonary aspergillosis in children with cystic fibrosis.

Authors:  S Maguire; P Moriarty; E Tempany; M FitzGerald
Journal:  Pediatrics       Date:  1988-12       Impact factor: 7.124

5.  The pathology of fungal infection and colonization in patients with cystic fibrosis.

Authors:  V Bhargava; J F Tomashefski; R C Stern; C R Abramowsky
Journal:  Hum Pathol       Date:  1989-10       Impact factor: 3.466

  5 in total
  7 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 2.  Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?

Authors:  A Hamprecht; F Morio; O Bader; P Le Pape; J Steinmann; E Dannaoui
Journal:  Mycopathologia       Date:  2017-06-26       Impact factor: 2.574

Review 3.  Allergic bronchopulmonary aspergillosis.

Authors:  Richard B Moss
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

Review 4.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

5.  Impact of mold infections in explanted lungs on outcomes of lung transplantation.

Authors:  Aniket Vadnerkar; Cornelius J Clancy; Umit Celik; Samuel A Yousem; Dimitra Mitsani; Yoshiya Toyoda; Minh-Ly Nguyen; Eun J Kwak; Joseph Pilewski; Fernanda P Silveira; Maria Crespo; M Hong Nguyen
Journal:  Transplantation       Date:  2010-01-27       Impact factor: 4.939

Review 6.  [Lung cavities, mycetomas and hemoptysis].

Authors:  Wolfgang Domej; Josef Hermann; Robert Krause; Martin Wehrschütz; Alfred Maier; Erich Flögel
Journal:  Wien Med Wochenschr       Date:  2007

Review 7.  Update on Respiratory Fungal Infections in Cystic Fibrosis Lung Disease and after Lung Transplantation.

Authors:  Sabine Renner; Edith Nachbaur; Peter Jaksch; Eleonora Dehlink
Journal:  J Fungi (Basel)       Date:  2020-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.